SENISCA Revenue and Competitors

Exeter, Devon

Location

$11M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SENISCA's estimated annual revenue is currently $1.9M per year.(i)
  • SENISCA's estimated revenue per employee is $77,500
  • SENISCA's total funding is $11M.

Employee Data

  • SENISCA has 24 Employees.(i)
  • SENISCA grew their employee count by -11% last year.

SENISCA's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating Officer, Co-founderReveal Email/Phone
3
Founder and CSOReveal Email/Phone
4
Chief Development OfficerReveal Email/Phone
5
Head Discovery ResearchReveal Email/Phone
6
Head Dermatology and Early Preclinical ResearchReveal Email/Phone
7
Head Oligotherapeutic DevelopmentReveal Email/Phone
8
VP DermatologyReveal Email/Phone
9
Commercial and Partnerships DirectorReveal Email/Phone
10
Executive AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.9M24-11%$10.7MN/A
Add Company

What Is SENISCA?

SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics).Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells.At SENISCA, we are using this knowledge, concerning how and why cells become senescent, to develop a new generation of oligonucleotide-based interventions, to turn back the ageing clock in old cells and to target the diseases and aesthetic signs of ageing.

keywords:N/A

$11M

Total Funding

24

Number of Employees

$1.9M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M24-4%N/A
#2
$2.5M2525%N/A
#3
$4.5M264%N/A
#4
$2.7M26-7%N/A
#5
$2.8M2793%N/A